In the current study, we found that high expression of DUSP26 has a direct impact on multiple signaling pathways, including MAP kinase and Akt pathways, suggesting that loss of DUSP26 expression is a crucial regulatory event associated with over activation of pro-tumor signaling in GBM cells. Here, DUSP26 is linked to neoplasm.